Morgan Stanley (MS) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

16.07.25 15:30 Uhr

Werte in diesem Artikel
Aktien

120,90 EUR -1,90 EUR -1,55%

76,00 EUR -0,50 EUR -0,65%

Indizes

PKT PKT

17.307,4 PKT 114,9 PKT 0,67%

3.086,0 PKT 10,1 PKT 0,33%

6.263,7 PKT 19,9 PKT 0,32%

Morgan Stanley (MS) reported $16.79 billion in revenue for the quarter ended June 2025, representing a year-over-year increase of 11.8%. EPS of $2.13 for the same period compares to $1.82 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $15.92 billion, representing a surprise of +5.49%. The company delivered an EPS surprise of +10.36%, with the consensus EPS estimate being $1.93.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Morgan Stanley performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Book value per common share: $61.59 compared to the $60.90 average estimate based on five analysts.Return on average common equity: 13.9% compared to the 13.1% average estimate based on four analysts.Wealth Management - Total client assets: $6,492.00 billion compared to the $5,962.28 billion average estimate based on two analysts.Total assets under management: $1,713.00 billion versus $1,640.63 billion estimated by two analysts on average.Net revenues- Investment Management: $1.55 billion compared to the $1.52 billion average estimate based on four analysts. The reported number represents a change of +12% year over year.Net revenues- Institutional Securities: $7.64 billion versus $7.43 billion estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +9.5% change.Revenues- Wealth Management- Net interest income: $1.91 billion versus $1.87 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +6.2% change.Total non-interest revenues: $14.45 billion compared to the $13.65 billion average estimate based on three analysts. The reported number represents a change of +11.5% year over year.Revenues- Investment banking: $1.64 billion compared to the $1.61 billion average estimate based on three analysts. The reported number represents a change of -5.2% year over year.Revenues- Commissions and fees: $1.43 billion compared to the $1.34 billion average estimate based on three analysts. The reported number represents a change of +20.5% year over year.Revenues- Institutional securities- Sales and Trading- Fixed income: $2.18 billion compared to the $2.23 billion average estimate based on three analysts. The reported number represents a change of +9.1% year over year.Revenues- Institutional securities- Sales and trading- Equity: $3.72 billion versus $3.46 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +23.3% change.View all Key Company Metrics for Morgan Stanley here>>>Shares of Morgan Stanley have returned +8.8% over the past month versus the Zacks S&P 500 composite's +4.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent. Thousands have taken advantage of this opportunity.Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators, and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Morgan Stanley (MS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Morgan Stanley und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf CGI Group

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf CGI Group

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Morgan Stanley

Wer­bung

Analysen zu Morgan Stanley

DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
20.04.2021Morgan Stanley kaufenCredit Suisse Group
DatumRatingAnalyst
19.04.2023Morgan Stanley BuyJefferies & Company Inc.
14.04.2022Morgan Stanley BuyGoldman Sachs Group Inc.
20.04.2021Morgan Stanley kaufenCredit Suisse Group
15.10.2020Morgan Stanley OutperformRBC Capital Markets
05.10.2020Morgan Stanley OutperformRBC Capital Markets
DatumRatingAnalyst
16.07.2024Morgan Stanley NeutralUBS AG
28.09.2021Morgan Stanley HoldJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
02.04.2020Morgan Stanley neutralDeutsche Bank AG
21.01.2020Morgan Stanley NeutralCitigroup Corp.
04.04.2019Morgan Stanley HoldHSBC
DatumRatingAnalyst
20.01.2016Morgan Stanley SellSociété Générale Group S.A. (SG)
25.07.2011Morgan Stanley underperformRBC Capital Markets
02.10.2009Morgan Stanley underperformCalyon Securities Inc.
31.08.2005Morgan Stanley underweightPrudential Financial
28.07.2005Morgan Stanley underweightPrudential Financial

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Morgan Stanley nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen